Cell Therapy
Amorcyte Cardiac Cell Therapy Trial Completes Second of Four Phases
Published in Medical Device Business Week, May 23rd, 2007
The trial will now await review of the data by the data safety monitoring board (DSMB) in accordance with the protocol.
"All treatment patients in the second cohort received intra-coronary artery infusion of a specified number of stem cells. The DSMB will review the data on this second treatment group and determine whether to give approval to start accruing patients in the next cohort at an increased pre-specified number of stem...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Acne Vulgaris
DUSA Pharmaceuticals Reports First Quarter 2007 Corporate Highlights and Financial Results - Angina
Cardiogenesis Announces Submission of PMA Supplement for Minimally Invasive Robotic Delivery System - Artificial Organs
HepaLife Expands Management Team on Heels of Favorable Outcomes of First-of-Its-Kind Bioartificial Liver Device - Back Pain
ACSS Spine Surgeons Hear Professor F.W. Smith, M.D. Report That the FONAR UPRIGHT MRI Successfully Diagnosed 54% of the Back Pain Patients That Could NOT Be Diagnosed by Recumbent MRI - Biomedical Engineering
Axela Biosensors to Develop Commercial Biomarker Assays with BioCheck's Antibody Reagents - Biomedical Engineering
California Healthcare Institute Applauds Introduction of R&D Tax Credit - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
